Although in the s.c. model, a trend of tumor growth inhibition was observed in the SFV/IFNg+Pam3-treated group, the tumor growth parameters and the final tumor weights varied within each group; therefore, the observed inhibition did not reach the level of significance (Figure 6a). This evidence concerns the gene IFNG and neoplasm.